No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study

Documents similaires

• No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
  par: Hopewell, J, et autres
  Publié: (2011)
• No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
  par: Hopewell, J, et autres
  Publié: (2011)
• Genetic variation in lipid response to statin therapy in 18,705 participants in the heart protection study
  par: Hopewell, J, et autres
  Publié: (2011)
• C-reactive protein in the Heart Protection Study Reply
  par: Emberson, J, et autres
  Publié: (2011)
• N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
  par: Emberson, J, et autres
  Publié: (2005)